Production of IL-13 in spleen cells by IL-18 and IL-12 through generation of NK-like cells

被引:5
|
作者
Ueda, Haruyasu [1 ]
Kashiwamura, Shin-ichiro [1 ]
Sekiyama, Atsuo [1 ]
Ogura, Takeharu [1 ]
Gamachi, Naomi [1 ]
Okamura, Haruki [1 ]
机构
[1] Hyogo Med Univ, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan
关键词
IL-18; IL-13; GM-CSF; CD25(+)NK-like cell; CD45RB;
D O I
10.1016/j.cyto.2005.08.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Treatment of Nylon wool-passed cells (NWC) prepared from the spleen of C57BL/6 mice with IL-18 and IL-12, but not with IL-18 alone, resulted in induction of IFN-gamma, a Th1 cytokine, and GM-CSF at 24 h. and IL-13, a Th2 cytokine at 72 h. The induction of IL-13 was suppressed by anti-GM-CSF antibody. indicating involvement of GM-CSF in IL-13 production. When NWC incubated with IL-18 and IL-12 for 72 h ("primary treatment") were treated again with the same cytokines ("secondary treatment"), IL-13 was induced much more quickly than observed in the primary treatment. Flow cytometric analysis of NWC after the primary treatment showed marked increases in the CD4(-)CD8(-) non-T cell population bearing CD25(+), CD45RB(super high) and CID 122(+). These cells were positive for CD49b but negative for NK1.1 indicating that they were not typical but NK-like cells. The NK-like cells produced IL-13 in response to the treatment with IL-18 alone. indicating that the generation of these cells in the primary treatment likely accounts for the quick production of IL-13 in (he secondary treatment. These results show that IL-18 and IL-12 generates the NK-like cells in NWC by a process mediated by GM-CSF that are ready for producing IL-13. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 50 条
  • [21] Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells
    Airoldi, I
    Gri, G
    Marshall, JD
    Corcione, A
    Facchetti, P
    Guglielmino, R
    Trinchieri, G
    Pistoia, V
    JOURNAL OF IMMUNOLOGY, 2000, 165 (12): : 6880 - 6888
  • [22] Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis
    Masanori Kawashima
    Pierre Miossec
    Arthritis Res Ther, 6
  • [23] IL-12/IL-13 axis in allergic asthma
    Wills-Karp, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (01) : 9 - 18
  • [24] In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18
    Baxevanis, CN
    Gritzapis, AD
    Papamichail, M
    JOURNAL OF IMMUNOLOGY, 2003, 171 (06): : 2953 - 2959
  • [25] Expression of IL-12 and IL-18 receptors in human neoplastic B cells.
    Pistoia, V
    Guglielmino, R
    Corcione, A
    Truini, M
    Airoldi, I
    BLOOD, 2001, 98 (11) : 330A - 330A
  • [26] Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis
    Kawashima, M
    Miossec, P
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (01) : R39 - R45
  • [27] Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18
    Ami, K
    Ohkawa, T
    Koike, Y
    Sato, K
    Habu, Y
    Iwai, T
    Seki, S
    Hiraide, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (03): : 453 - 459
  • [28] DC-activating function of cytokines [IL-12, IL-18], T cells and NK cells in the development of antitumor responses.
    Lotze, MT
    Mailliard, RB
    Tanaka, F
    Tahara, H
    Storkus, WJ
    Kalinksi, P
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S103 - S104
  • [29] Induction of host resistance to Leishmania major by IL-12 and IL-18: In vivo IL-12 treatment up-regulates IL-18 receptor expression on T cells.
    Yoshimoto, T
    Ohkusu, K
    Okamura, H
    Nakanishi, K
    FASEB JOURNAL, 1998, 12 (05): : A1068 - A1068
  • [30] Resistance of T cell acute lymphoblastic leukemia to autologous rat NK cells is reversed by IL-12, IL-15, and IL-18
    Boieri, Margherita
    Ulvmoen, Aina
    Sudworth, Amanda
    Lendrem, Clare
    Collin, Matthew
    Dickinson, Anne M.
    Kveberg, Lise
    Inngjerdingen, Marit
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 333 - 333